Melinta Therapeutics Revenue, Growth & Competitor Profile

DBA MELINTA SUBSIDIARY CORP.
DBA MELINTA THERAPEUTICS, INC. /NEW/
DBA Rib-X Pharmaceuticals, Inc.

Company Profile & Annual Report for Melinta Therapeutics

Access the complete profile.

Melinta Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	389 Interpace Pkwy Ste 450 Parsippany, NJ 07054

Note: Revenues for privately held companies are statistical evaluations.


Melinta Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Melinta Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Melinta Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Melinta Therapeutics Annual Revenue and Growth Rate

Melinta Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Melinta Therapeutics's revenues are gauged from an analysis of company filings.

Melinta Therapeutics's Income Statement (based on Industry Averages)

Melinta Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Melinta Therapeutics is developing and marketing. Melinta Therapeutics doesn't have any recent trademark applications, indicating Melinta Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
KIMYRSA Antibiotic preparations	07/07/2020
BYMRASA Antibiotic preparations	07/07/2020
MEBRYSA Antibiotic preparations	07/07/2020

See all trademarks and details in the Full Report.

Market Share of Melinta Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Melinta Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Melinta Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MERCK SHARP & DOHME	Rahway, NJ	100
MERCK	Rahway, NJ	95
ZOETIS	Parsippany, NJ	26
TEVA PHARMACEUTICALS USA	Parsippany, NJ	18
GLAXOSMITHKLINE CONSUMER HEALTHCARE	Warren, NJ	10
CAMBREX	East Rutherford, NJ	5

Future Competition: Melinta Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Melinta Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)